NasdaqCM - Nasdaq Real Time Price USD

ARCA biopharma, Inc. (ABIO)

3.2500

-0.0800

(-2.40%)

As of 10:39 AM EDT. Market Open.

Key Events

Loading Chart for ABIO

9/21 12:03 PM

DELL

Previous Close 3.3300
Open 3.2500
Bid 3.1700 x 100
Ask 3.3400 x 100
Day's Range 3.2000 - 3.2999
52 Week Range 1.5600 - 4.4900
Volume 52,226
Avg. Volume 1,470,772
Market Cap (intraday) 47.148M
Beta (5Y Monthly) 0.88
PE Ratio (TTM) --
EPS (TTM) -0.4200
Earnings Date Jul 19, 2024 - Jul 23, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.

www.arcabio.com

4

Full Time Employees

December 31

Fiscal Year Ends

Sector

Industry

Trailing total returns as of 5/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ABIO

91.18%

S&P 500

11.58%

1-Year Return

ABIO

59.31%

S&P 500

26.96%

3-Year Return

ABIO

2.69%

S&P 500

29.32%

5-Year Return

ABIO

65.46%

S&P 500

86.12%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

ARCA biopharma, Inc.

3.2500

-2.40%

Mkt Cap 47.148M

Industry Biotechnology

Biodexa Pharmaceuticals Plc

1.2400

+4.24%

Mkt Cap 5.437M

Industry Biotechnology

Cyclacel Pharmaceuticals, Inc.

2.3100

+0.87%

Mkt Cap 3.38M

Industry Biotechnology

Biomea Fusion, Inc.

12.49

+2.04%

Mkt Cap 448.948M

Industry Biotechnology

CytomX Therapeutics, Inc.

1.8775

-0.66%

Mkt Cap 146.294M

Industry Biotechnology

Ocean Biomedical, Inc.

1.6900

-3.98%

Mkt Cap 58.557M

Industry Biotechnology

Bolt Biotherapeutics, Inc.

0.7970

+0.52%

Mkt Cap 30.388M

Industry Biotechnology

Reneo Pharmaceuticals, Inc.

1.7200

-1.71%

Mkt Cap 57.484M

Industry Biotechnology

Aligos Therapeutics, Inc.

0.6797

-1.29%

Mkt Cap 53.091M

Industry Biotechnology

Candel Therapeutics, Inc.

11.85

+3.09%

Mkt Cap 352.614M

Industry Biotechnology

Allarity Therapeutics, Inc.

0.6187

-3.20%

Mkt Cap 1.596M

Industry Biotechnology

Valuation Measures

As of 5/17/2024

Market Cap

48.31M
Enterprise Value

12.41M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

--
Price/Book (mrq)

1.38
Enterprise Value/Revenue

--
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-12.67%
Return on Equity (ttm)

-15.87%
Revenue (ttm)

--
Net Income Avi to Common (ttm)

-6M
Diluted EPS (ttm)

-0.4200

Balance Sheet and Cash Flow

Total Cash (mrq)

35.9M
Total Debt/Equity (mrq)

0.14%
Levered Free Cash Flow (ttm)

-3.84M

ABIO does not have Company Insights

CYCC Cyclacel Pharmaceuticals, Inc.

2.3100

+0.87%

CAPR Capricor Therapeutics, Inc.

6.29

+1.45%

BPTH Bio-Path Holdings, Inc.

2.1560

+0.75%

PRPO Precipio, Inc.

6.10

-2.24%

ACHV Achieve Life Sciences, Inc.

4.8600

-2.80%

VTVT vTv Therapeutics Inc.

27.38

-1.87%

TENX Tenax Therapeutics, Inc.

3.6205

+2.56%

SNOA Sonoma Pharmaceuticals, Inc.

0.2221

-5.94%

BIOC Biocept, Inc.

0.4349

0.00%

AEZS Aeterna Zentaris Inc.

8.52

-0.23%

AKTX Akari Therapeutics, Plc

1.5800

+3.95%

PHIO Phio Pharmaceuticals Corp.

0.7796

-0.98%

ADIL Adial Pharmaceuticals, Inc.

1.5108

-2.53%

OPGN OpGen, Inc.

4.1100

-10.65%

XBIO Xenetic Biosciences, Inc.

3.8379

+6.31%

ABUS Arbutus Biopharma Corporation

3.0500

+2.36%